Advisor Group Holdings, Inc. Intellia Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 35,355 shares of NTLA stock, worth $464,211. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,355
Previous 37,129 4.78%
Holding current value
$464,211
Previous $830,000 12.53%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$19.72 - $27.36 $34,983 - $48,536
-1,774 Reduced 4.78%
35,355 $726,000
Q2 2024

Aug 13, 2024
SELL
$20.02 - $27.22 $600 - $816
-30 Reduced 0.08%
37,129 $830,000
Q1 2024

May 10, 2024
BUY
$23.82 - $32.8 $30,441 - $41,918
1,278 Added 3.56%
37,159 $1.02 Million
Q4 2023

Feb 12, 2024
BUY
$23.16 - $32.34 $275,094 - $384,134
11,878 Added 49.49%
35,881 $1.09 Million
Q3 2023

Nov 13, 2023
BUY
$31.62 - $45.78 $125,784 - $182,112
3,978 Added 19.87%
24,003 $758,000
Q2 2023

Aug 10, 2023
SELL
$34.58 - $46.03 $45,749 - $60,897
-1,323 Reduced 6.2%
20,025 $816,000
Q1 2023

May 12, 2023
BUY
$33.3 - $44.82 $34,432 - $46,343
1,034 Added 5.09%
21,348 $795,000
Q4 2022

Feb 10, 2023
BUY
$33.21 - $62.69 $422,497 - $797,542
12,722 Added 167.57%
20,314 $708,000
Q3 2022

Nov 14, 2022
BUY
$53.92 - $71.7 $808 - $1,075
15 Added 0.2%
7,592 $423,000
Q2 2022

Aug 10, 2022
SELL
$38.49 - $76.21 $41,107 - $81,392
-1,068 Reduced 12.35%
7,577 $391,000
Q1 2022

May 04, 2022
BUY
$58.27 - $118.99 $26,104 - $53,307
448 Added 5.47%
8,645 $826,000
Q3 2021

Nov 05, 2021
SELL
$132.37 - $176.78 $316,231 - $422,327
-2,389 Reduced 22.57%
8,197 $1.1 Million
Q2 2021

Aug 02, 2021
SELL
$60.88 - $161.91 $79,813 - $212,264
-1,311 Reduced 11.02%
10,586 $1.72 Million
Q1 2021

May 13, 2021
BUY
$46.59 - $83.68 $37,737 - $67,780
810 Added 7.31%
11,897 $954,000
Q4 2020

Feb 10, 2021
BUY
$18.83 - $63.53 $27,604 - $93,134
1,466 Added 15.24%
11,087 $602,000
Q3 2020

Nov 12, 2020
SELL
$17.47 - $24.93 $5,083 - $7,254
-291 Reduced 2.94%
9,621 $191,000
Q2 2020

Aug 14, 2020
SELL
$11.14 - $22.87 $40,404 - $82,949
-3,627 Reduced 26.79%
9,912 $208,000
Q1 2020

May 18, 2020
BUY
$9.44 - $15.58 $127,808 - $210,937
13,539 New
13,539 $168,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $998M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email